89
Participants
Start Date
October 31, 2008
Primary Completion Date
February 28, 2009
Study Completion Date
February 28, 2009
EGP-437 with EyeGate® II System
Transscleral iontophoretic delivery of EGP-437 (dexamethasone phosphate ophthalmic solution 40 mg/mL) delivered via EyeGate® II Drug Delivery System
Sodium citrate buffer solution with EyeGate® II System
Transscleral iontophoretic delivery of sodium citrate buffer solution 100 mM delivered via EyeGate® II Drug Delivery System
Ophthalmic Research Associates, Andover
Ophthalmic Research Associates, North Andover
Lead Sponsor
Eyegate Pharmaceuticals, Inc.
INDUSTRY